ASX - Delayed Quote • AUD
Proteomics International Laboratories Limited (PIQ.AX)
At close: April 24 at 3:20 PM GMT+10
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | 1 |
| Avg. Estimate | 0 | 0 | 0 | -0.04 |
| Low Estimate | 0 | 0 | 0 | -0.04 |
| High Estimate | 0 | 0 | 0 | -0.04 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | -0.04 |
| 7 Days Ago | 0 | 0 | -0.06 | -0.04 |
| 30 Days Ago | 0 | 0 | -0.06 | -0.04 |
| 60 Days Ago | 0 | 0 | -0.06 | -0.04 |
| 90 Days Ago | 0 | 0 | -0.06 | -0.04 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PIQ.AX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.50% |
| Next Qtr. | -- | -- | -- | 11.40% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker
Related Tickers
CYP.AX Cynata Therapeutics Limited
0.2100
+5.00%
HXL.AX Hexima Limited
0.0130
0.00%
TRP.AX Tissue Repair Ltd
0.2300
0.00%
PAB.AX Patrys Limited
0.0090
0.00%
OPT.AX Opthea Limited
0.6750
0.00%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0520
-1.89%
MEM.AX Memphasys Limited
0.0080
0.00%
VBS.AX Vectus Biosystems Limited
0.2750
0.00%
ILA.AX Island Pharmaceuticals Limited
0.0530
0.00%
PTX.AX Prescient Therapeutics Limited
0.0580
+1.75%